Global Transcatheter Pulmonary Valves Market to Reach $115 Million by 2030
The global market for Transcatheter Pulmonary Valves estimated at US$81.6 Million in the year 2022, is projected to reach a revised size of US$115 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2022-2030. Balloon-Expanded, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$74.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Self-Expanded segment is readjusted to a revised 3.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $22.2 Million, While China is Forecast to Grow at 8.9% CAGR
The Transcatheter Pulmonary Valves market in the U.S. is estimated at US$22.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$27.1 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.4% and 3.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.Select Competitors (Total 42 Featured) -
- Boston Scientific Corporation
- Braile Biomedica
- Colibri Heart Valve LLC
- Cryolife Inc.
- Direct Flow Medical Inc.
- Edward Lifesciences Corporation
- Jenavalve Technology Inc.
- Livanova plc
- Medtronic
- St. Jude Medical
- Venus Medtech
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corporation
- Braile Biomedica
- Colibri Heart Valve LLC
- Cryolife Inc.
- Direct Flow Medical Inc.
- Edward Lifesciences Corporation
- Jenavalve Technology Inc.
- Livanova plc
- Medtronic
- St. Jude Medical
- Venus Medtech
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 81.6 Million |
Forecasted Market Value ( USD | $ 115 Million |
Compound Annual Growth Rate | 4.4% |
Regions Covered | Global |